The role of interleukin-24 in atopic dermatitis
Atopic dermatitis (AD) is characterized by skin barrier disruption, type 2 immune dysregulation, chronic pruritus, and abnormal colonization by Staphylococcus aureus (S. aureus). Tapinarof, an aryl hydrocarbon receptor modulator, has been demonstrated to attenuate the development of AD in clinical s...
Enregistré dans:
Auteurs principaux: | Yen Hai Vu, Masutaka Furue, Gaku Tsuji |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Open Exploration Publishing Inc.
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/856e2ee9c914464eabc7d770cfa8b188 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Janus Kinase Inhibitors for the Treatment of Atopic Dermatitis: Focus on Abrocitinib, Baricitinib, and Upadacitinib
par: Miguel Nogueira, et autres
Publié: (2021) -
The New Era of Biologics in Atopic Dermatitis: A Review
par: Simon Schneider, et autres
Publié: (2021) -
Dupilumab side effect in a patient with atopic dermatitis: a case report study
par: Albader SS, et autres
Publié: (2019) -
Interleukin-22 and keratinocytes; pathogenic implications in skin inflammation
par: Masutaka Furue, et autres
Publié: (2021) -
Efficacy of Dupilumab for Atopic Dermatitis According to Clinical Course and Clinical Findings: A Multicentre Retrospective Study
par: Takeshi Nakahara, et autres
Publié: (2021)